ID   CTSC-2
AC   CVCL_XB88
DR   Wikidata; Q93460214
RX   Patent=CN102911916A;
CC   Group: Patented cell line.
CC   Population: Chinese.
CC   Doubling time: 31.48 +- 0.79 hours (Note=At 10th passage), 32.72 +- 0.81 hours (Note=At 30th passage) (Patent=CN102911916A).
CC   Derived from site: In situ; Oral cavity, tongue; UBERON=UBERON_0001723.
ST   Source(s): Patent=CN102911916A
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D12S391: 18,19
ST   D13S317: 8,9
ST   D16S539: 9
ST   D18S51: 15
ST   D21S11: 32.2,33.2
ST   D3S1358: 15,16
ST   D5S818: 13,14
ST   D6S1043: 14,18
ST   D7S820: 11,13
ST   D8S1179: 12,15
ST   FGA: 20,25
ST   Penta D: 7,9
ST   Penta E: 19,20
ST   TH01: 7
ST   TPOX: 8,9
ST   vWA: 14,18
DI   NCIt; C4648; Tongue squamous cell carcinoma
DI   ORDO; Orphanet_457252; Squamous cell carcinoma of the oral tongue
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 6
//
RX   Patent=CN102911916A;
RA   Zhang Y., He H., Zhang H.-X., Wang H.;
RT   "Chinese tongue squamous cancer cell line (CTSC-2) and establishing
RT   method thereof.";
RL   Patent number CN102911916A, 06-Feb-2013.
//